Supplementary Data for "Proof-of-concept and randomized, placebo-controlled trials of an FcRn inhibitor, batoclimab, for thyroid eye disease"
Published: 26 June 2023| Version 1 | DOI: 10.17632/m9fmzz3rk5.1
Contributor:
Jonathan JanesDescription
Supplemental data file.
Files
Categories
Autoimmunity, Clinical Trial, Thyroid Eye Disease, Autoantibody, Immunoglobulin G
Funding
Immunovant Sciences GmbH